Siahi Mohammad Reza, Rahimi Soma, Monajjemzadeh Farnaz
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Pharmaceutical and Food Control, Tabriz University of Medical Sciences, Faculty of Pharmacy, Tabriz, Iran.
Adv Pharm Bull. 2018 Nov;8(4):657-666. doi: 10.15171/apb.2018.074. Epub 2018 Nov 29.
Assessment of drug substance and excipients compatibility is an important issue during pre-formulation studies as well as the quality control of pharmaceutical dosage forms. In this study, potential incompatibility between methyldopa and reducing excipients was evaluated using physicochemical methods. Dextrose and lactose (anhydrous & monohydrate) were selected as reducing carbohydrates. The initial incompatibility was studied with DSC and FTIR on binary mixtures with 1:1 mass ratio. Results were confirmed using HPLC studies coupled with mass spectrometry. The DSC curves indicated the elimination of the melting endotherm of methyldopa in the binary mixtures. A new peak at 1719 cm-1 was observed in the FTIR spectra that can be attributed to the loss of type one amine functionality. The m/z of the proposed compound was observed in the mass spectra. The potential incompatibility of Methyldopa with reducing carbohydrates was established using physicochemical methods.
在制剂前研究以及药物剂型的质量控制过程中,原料药与辅料的相容性评估是一个重要问题。在本研究中,采用物理化学方法评估了甲基多巴与还原性辅料之间的潜在不相容性。选择葡萄糖和乳糖(无水及一水合物)作为还原性碳水化合物。通过差示扫描量热法(DSC)和傅里叶变换红外光谱法(FTIR)对质量比为1:1的二元混合物进行研究,以探究初始不相容性。使用高效液相色谱(HPLC)结合质谱法对结果进行了确认。DSC曲线表明二元混合物中甲基多巴的熔融吸热峰消失。在FTIR光谱中观察到一个位于1719 cm-1的新峰,这可归因于一级胺官能团的损失。在质谱中观察到了所提出化合物的质荷比。采用物理化学方法确定了甲基多巴与还原性碳水化合物之间的潜在不相容性。